Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIVE Study of liraglutide integrated into a Tier 3 obesity service
2017-002998-20Phase 4Unknown
- Sponsor
- University of Leicester
- Start
- May 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of liraglutide in obesity (2 arms), sponsored by University of Leicester. Status: unknown.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on 2017-002998-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002998-20.